๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study

โœ Scribed by Sharma, A M; Wagner, T; Marsalek, P


Book ID
110048644
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
132 KB
Volume
18
Category
Article
ISSN
0950-9240

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Moxonidine in the treatment of overweigh
โœ Sharma, A M; Wagner, T; Marsalek, P ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 132 KB

Moxonidine is a centrally active imidazoline receptor agonist that effectively lowers blood pressure and has been shown to have beneficial effects on lipid and carbohydrate metabolism. We assessed the efficacy of moxonidine in a postmarketing surveillance study (CAMUS) conducted in 772 practices in